HIGHLIGHTS
- who: Keisuke Okuno et al. from the Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Biomedical Research Center, Monrovia, CA, USA Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, Tokyo, Japan have published the research work: Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma, in the Journal: Biomedicines 2023, 11, 119. of 23/Nov/2022
- what: The authors demonstrate novel evidence for Andro-mediated reversal of chemoresistance to Gem in PDAC cells through the regulation of and calcium signaling. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.